| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4df108cb4c2f6009ddbfe8c1e3093cd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5416cbf9cb79c9d01ab2a51bf05a5ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a522c76053133dd1b55ca21326fef33f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab8a388a7eb36be9437a476e7c888076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6096d3bf29df1c6ccb5016e18e0185e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_678f8f95bc573cf6d2338bf63e276089 |
| publicationDate |
2016-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016024246-A1 |
| titleOfInvention |
A therapeutic use of naadp and/or tcp2 antagonists |
| abstract |
There is described the therapeutic use of nicotinic acid adenine-dinucleotide phosphate (NAADP) or two-pore channel TCP2 subtype antagonists, in the treatment of diseases characterized by VEGF-induced neovascularization. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018070774-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019020643-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018091598-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3434692-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3323415-A1 |
| priorityDate |
2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |